EUVIMEDEUVIMED entdecken
Open Access

Pharmacokinetics/pharmacodynamics cut-off determination for fosfomycin using Monte Carlo simulation in healthy horses

Taisuke Kuroda, Yohei Minamijima, Hidekazu Niwa, Hiroshi Mita, Norihisa Tamura, Kentaro Fukuda, Pierre-Louis Toutain, Minoru Ohta

Journal of Veterinary Medical Science · 2024

DOI: 10.1292/jvms.23-0476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Medical Science, 2024. Verfasst von Taisuke Kuroda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Tochigi, Japan. Hauptthemen laut MEDLINE: Fosfomycin, Escherichia coli Infections, Horse Diseases. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fosfomycin (FOM) is an approved veterinary medicinal product for large animals in Japan, but Clinical breakpoint (CBP) for antimicrobial susceptibility test (AST) is not defined for animals. This study aimed at conducting a pharmacokinetics/pharmacodynamics (PK/PD) analysis to determine the PK/PD cutoff for the CBP in horses. Drug concentrations following single intravenous administration (IV) of 20 mg/kg body weight (BW) FOM in nine horses were measured using liquid chromatography/mass spectrometry. The data were modelled using a nonlinear mixed-effects model, followed by Monte Carlo simulations. A 90% probability of target attainment for a PK/PD target of the ratio of Area Under the free plasma concentration-time curve divided by the minimal inhibitory concentration (MIC) >24 hr was set as PK/PD cut-off. The PK/PD cutoff for FOM 20 mg/kg BW q12 hr IV was estimated with the MIC value of ≤16.0 mg/L, and this regimen was considered effective against E. coli (MIC90; 16.0 mg/L) in healthy horses based on the MIC90 values of the wild population. Owing to the relevance of FOM to human health, veterinarians should use q 12 hr FOM 20 mg /kg against E. coli infections with an MIC

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FosfomycinEscherichia coli InfectionsHorse DiseasesHumansAnimalsHorsesAnti-Bacterial AgentsEscherichia coliMonte Carlo MethodMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Escherichia coliantimicrobial susceptibility testingfosfomycinhorsepharmacokinetics/pharmacodynamics (PK/PD) cutoff

Substanzen

FosfomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Clinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Tochigi, Japan.
  • Drug Analysis Department, Laboratory of Racing Chemistry, Tochigi, Japan.
  • Microbiology Division, Equine Research Institute, Japan Racing Association, Tochigi, Japan.
  • Comparative Biomedical Sciences, The Royal Veterinary College, London, United Kingdom.
  • Intheres, Ecole Nationale Vétérinaire de Toulouse, France.

Zitieren

APA

Kuroda, T., Minamijima, Y., Niwa, H., Mita, H., Tamura, N., Fukuda, K., Toutain, P. L., & Ohta, M. (2024). Pharmacokinetics/pharmacodynamics cut-off determination for fosfomycin using Monte Carlo simulation in healthy horses. Journal of Veterinary Medical Science. https://doi.org/10.1292/jvms.23-0476

Vancouver

Kuroda T, Minamijima Y, Niwa H, Mita H, Tamura N, Fukuda K, et al. Pharmacokinetics/pharmacodynamics cut-off determination for fosfomycin using Monte Carlo simulation in healthy horses. Journal of Veterinary Medical Science. 2024. doi:10.1292/jvms.23-0476

BibTeX
@article{Kuroda2024,
  author = {Kuroda, Taisuke and Minamijima, Yohei and Niwa, Hidekazu and Mita, Hiroshi and Tamura, Norihisa and Fukuda, Kentaro and Toutain, Pierre-Louis and Ohta, Minoru},
  title = {Pharmacokinetics/pharmacodynamics cut-off determination for fosfomycin using Monte Carlo simulation in healthy horses},
  journal = {Journal of Veterinary Medical Science},
  year = {2024},
  doi = {10.1292/jvms.23-0476}
}
Kostenlos starten →